BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35537854)

  • 41. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    Ampuero J; Montoliú C; Simón-Talero M; Aguilera V; Millán R; Márquez C; Jover R; Rico MC; Sendra C; Serra MÁ; Romero-Gómez M
    J Gastroenterol Hepatol; 2018 Mar; 33(3):718-725. PubMed ID: 28768371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study.
    Hernández-Conde M; Fernández-Carrillo C; Llop E; Perelló C; López-Gómez M; Martínez-Porras JL; Fernández-Puga N; Calleja JL
    Ann Hepatol; 2019; 18(3):429-433. PubMed ID: 31054981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.
    Özel Coşkun BD; Özen M
    Turk J Gastroenterol; 2017 May; 28(3):191-196. PubMed ID: 28316320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
    Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.
    Li SW; Wang K; Yu YQ; Wang HB; Li YH; Xu JM
    World J Gastroenterol; 2013 Dec; 19(46):8745-51. PubMed ID: 24379595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2010; 16(3):181-7. PubMed ID: 20616413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.
    Bajaj JS; Hylemon PB; Ridlon JM; Heuman DM; Daita K; White MB; Monteith P; Noble NA; Sikaroodi M; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(6):G675-85. PubMed ID: 22821944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
    Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum and urinary metabolomics and outcomes in cirrhosis.
    Bajaj JS; Fan S; Thacker LR; Fagan A; Gavis E; White MB; Heuman DM; Fuchs M; Fiehn O
    PLoS One; 2019; 14(9):e0223061. PubMed ID: 31560724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
    Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
    Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and evaluation of a virtual reality driving test for patients with cirrhosis.
    Gairing SJ; Schleicher EM; Kaps L; Schulte-Beerbuehl S; Steiner K; Labenz J; Schattenberg JM; Galle PR; Wörns MA; Labenz C
    Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37902506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access.
    Acharya C; Bajaj JS
    Liver Transpl; 2021 Dec; 27(12):1830-1843. PubMed ID: 34018659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
    World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis.
    Bajaj JS; Reddy KR; Tandon P; Garcia-Tsao G; Kamath PS; O'Leary JG; Wong F; Lai J; Vargas H; Thuluvath PJ; Subramanian RM; Pena-Rodriguez M; Sikaroodi M; Thacker LR; Gillevet PM
    Liver Transpl; 2022 Dec; 28(12):1831-1840. PubMed ID: 36017804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.
    Kaps L; Hildebrand K; Nagel M; Michel M; Kremer WM; Hilscher M; Galle PR; Schattenberg JM; Wörns MA; Labenz C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101873. PubMed ID: 35124289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.